Home-Based Heat Therapy in Spinal Cord Injury to Improve Cardiovascular Health
IIS_SCIDoD
Home-Based Passive Heat Therapy-Towards a Scalable Intervention to Improve Cardiovascular Health in Persons With Spinal Cord Injury
2 other identifiers
interventional
48
1 country
1
Brief Summary
The study is designed to investigate the effects of passive heat therapy on blood vessel health in 40 people (48 enrolled with attrition rate of 20%). Following an extensive set of vascular function tests, participants will engage in either a passive heat therapy intervention for 60 minutes, 4 times a week for 8 weeks, or a placebo intervention at a lower temperature. Seven of the 8 weeks of intervention will occur in the home setting. Vascular function tests will be repeated after the 8 weeks to determine if chronic passive heat stress improved vascular health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 18, 2025
CompletedFirst Posted
Study publicly available on registry
January 5, 2026
CompletedStudy Start
First participant enrolled
March 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2031
May 5, 2026
April 1, 2026
4.7 years
December 18, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Laser Doppler Flowmetry (LDF)
Measure of skin blood flow due to local skin heating
From baseline to end of treatment at 8 weeks
Secondary Outcomes (3)
Endothelial Peripheral Arterial Tone (EndoPAT)
Baseline to end of treatment at 8 weeks
Venous Occlusion Plethysmography (VOP)
From baseline to end of treatment at 8 weeks
Cardiac MRI
Baseline to end of treatment at 8 weeks
Study Arms (2)
HEAT
EXPERIMENTALThe experimental arm (HEAT) participants undergo an 8-week intervention with 4 weekly passive heat therapy sessions (home based for 7 of 8 weeks) using an electrical heating blanket at a temperature of 42 degrees C.
SHAM
SHAM COMPARATORFor participants in SHAM, the heating blankets will be warm (\~34°C) but will not reach a temperature that elevates core temperature. As in the HEAT arm, sessions will be home based for 7 of 8 weeks.
Interventions
Participant rests under a heated blanket until the core body temperature has increased at minimum 1 degree Celsius. This usually takes approximately 1 hour. The intervention is performed 4 times a week for a total of 8 weeks.
The SHAM intervention participant will rest under a heated blanket that is not set to the degree that the HEAT arm receives. There is no increase of core body temperature.
Eligibility Criteria
You may qualify if:
- Participant demonstrates understanding of the study and has provided an appropriately signed and dated informed consent.
- Participants will be male or female, 18-60 years of age, at the time of Visit 0.
- Female participants must be non-lactating. Female patients are eligible only if they have a negative pregnancy test throughout the study period (or are postmenopausal). Postmenopausal women taking hormone replacement will be included if they have been on a stable dose for =6 months.
- Stable SCI (AIS A or B) of longer than 1-year duration.
You may not qualify if:
- Participants who smoke, or:
- Uses daily administration of vasoactive medications (e.g., alpha antagonists or agonists or phosphodiesterase inhibitors).
- Has a current pressure ulcer or skin breakdown.
- Has an active, uncontrolled, autoimmune or inflammatory disorder
- Has no history of or current alcohol or substance use disorder
- Has a history of heat related illness (e.g., heat stroke)
- Has a history of any illness that, in the opinion of the study investigator, might confound the results of the study or poses an additional risk to the participant by their participation in the study. This includes, but is not limited to, a clinically relevant medical or surgical history.
- Is unlikely to cooperate with the requirements of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Audie L Murphy Veterans Memorial Hospital, South Texas Veterans Health Care System
San Antonio, Texas, 78229, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle Trbovich, MD
The University of Texas Health Science Center at San Antonio
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2025
First Posted
January 5, 2026
Study Start
March 24, 2026
Primary Completion (Estimated)
December 1, 2030
Study Completion (Estimated)
July 1, 2031
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share